S. 4651

S. 4651: A bill to amend the Federal Crop Insurance Act to increase access to Federal crop insurance for specialty crops.

Introduced Adam Schiff (D) SENATE_BILL — 119th Congress
Plain English Summary

S. 4651 is a bill aimed at amending the Federal Crop Insurance Act to enhance access to federal crop insurance specifically for specialty crops. This likely involves provisions to make it easier for farmers growing specialty crops, such as fruits, vegetables, and nuts, to obtain insurance coverage that protects them against losses due to adverse weather or other risks.

Positive Media Summary

Media coverage has highlighted the importance of this bill for supporting specialty crop farmers, who often face unique challenges that differ from those of commodity crop farmers. Advocates argue that increasing access to crop insurance can lead to greater financial stability for these farmers and encourage the growth of local food systems.

Negative Media Summary

Critics have expressed concerns that the bill may divert resources from traditional crop insurance programs, potentially undermining support for staple crops. Some agricultural organizations argue that the focus on specialty crops could lead to inequities in federal support and question whether the increased funding is justified.

Conflict of Interest Analysis Deep Analysis
2/10
Risk Level
Low
Total Donations
$0
PAC Percentage
0%
Policy Area
Agriculture and Food

The analysis of bill S. 4651, which aims to amend the Federal Crop Insurance Act to enhance access for specialty crops, reveals no direct industry overlaps between the sponsor Adam Schiff's top donor industries and the bill's subject matter. The top donor industries do not appear to have a vested interest in crop insurance, suggesting a low risk of conflicts of interest. Furthermore, while there is significant lobbying activity in related areas, such as CEDIA's $120,000 contribution, it does not directly pertain to specialty crops or crop insurance, which further mitigates potential conflicts. Voters should be aware that while lobbying exists, it does not directly connect to the sponsor's financial backers in this instance.

Lobbying Activity — Who's Pushing?

Organizations that lobbied on issues related to this bill's policy area.

Client Lobbying Firm Amount
FRIENDS COMMITTEE ON NATIONAL LEGISLATION FRIENDS COMMITTEE ON NATIONAL LEGISLATION $1,000,000
CEDIA CEDIA $120,000
HEARTFLOW, INC. HEARTFLOW, INC. $90,000
KNOA PHARMA LLC MERCURY PUBLIC AFFAIRS, LLC undisclosed
HELIX DEFENSE CROSS POTOMAC CONSULTING LLC undisclosed
SUR HOLDINGS BGR GOVERNMENT AFFAIRS undisclosed
GLOBAL KRATOM COALITION BGR GOVERNMENT AFFAIRS undisclosed
GIBSON, DUNN & CRUTCHER, LLP ON BEHALF OF CURATIVE INC. BGR GOVERNMENT AFFAIRS undisclosed
ORCA BIO BGR GOVERNMENT AFFAIRS undisclosed
IONQ, INC. IONQ, INC. undisclosed
LIFE360 EMERGENT STRATEGIES undisclosed
ZILLOW BGR GOVERNMENT AFFAIRS undisclosed
TWENTY TECHNOLOGIES, INC. THE COMPLETE AGENCY undisclosed
CULTURAL CARE INC. KEEFE STRATEGIES LLC FKA KEEFE SINGISER PARTNERS undisclosed
INTERNATIONAL ASSOCIATION OF FORENSIC NURSES POLSINELLI PC undisclosed

Source: Senate Lobbying Disclosure Act (LDA) filings, 2026

Sponsor's Top Donor Industries

Top industries funding Adam Schiff, ranked by total contributions.

Health Professionals $120,000,000
Individuals: $120,000,000 PACs: $0
Retired $37,500,000
Individuals: $37,500,000 PACs: $0

Source: OpenSecrets.org (Center for Responsive Politics)

TheBillRoom is free and independent. No ads, no subscriptions, no political funding. If this analysis was useful, reader support keeps it running.
Support Us